<?xml version="1.0" encoding="UTF-8"?>
<p>In December 2019, a novel pneumonia syndrome was identified in patients clustered around the Huanan Seafood Market in Wuhan, China.
 <sup>
  <xref rid="R1" ref-type="bibr">1</xref>,
  <xref rid="R2" ref-type="bibr">2</xref>
 </sup> Next generation sequencing was used to identify a novel coronavirus, now known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), in bronchoalveolar lavage fluid from three of these patients. Infection with SARS-CoV-2 leads to the syndrome of Coronavirus Disease 2019 (COVID-19). Rapid international spread of this potentially lethal virus has caused global concern, with 110,000 cases and 3,800 deaths reported to date.
 <sup>
  <xref rid="R2" ref-type="bibr">2</xref>,
  <xref rid="R3" ref-type="bibr">3</xref>
 </sup> Here, we will summarize the latest insights into the biology of SARS-CoV-2 and their implications for anesthesiologists in perioperative and intensive care settings.
</p>
